WYNN
34
-2
TMO
54
-2
MAR
57
-3
MTB
38
-3
BAC
39
-3
DIS
68
-4
COF
49
-3
ACN
49
-7
MOS
36
-3
NAVI
35
-5
DG
14
-2
XRX
55
-2
KSS
39
-3
EW
55
-2
AVB
54
-3
GD
42
-2
RCL
62
-14
AME
48
-3
NWSA
65
-6
IVZ
48
-2
WYNN
34
-2
TMO
54
-2
MAR
57
-3
MTB
38
-3
BAC
39
-3
DIS
68
-4
COF
49
-3
ACN
49
-7
MOS
36
-3
NAVI
35
-5
DG
14
-2
XRX
55
-2
KSS
39
-3
EW
55
-2
AVB
54
-3
GD
42
-2
RCL
62
-14
AME
48
-3
NWSA
65
-6
IVZ
48
-2
Financhill
Back

LakeShore Biopharma 10K Form

Buy
55

LSB
LakeShore Biopharma

Last Price:
$3.35
Seasonality Move:
-12.42%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive LSB News And Ratings

See the #1 stock for the next 7 days that we like better than LSB

LSB Financial Statistics

Sales & Book Value

Annual Sales: $80.2M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $4.50
Price / Book: 0.74

Profitability

EPS (TTM): -2.00650
Net Income (TTM): $-6.7M
Gross Margin: $63.7M
Return on Equity: -7.94%
Return on Assets: -3.11%

LakeShore Biopharma Earnings Forecast

Key LakeShore Biopharma Financial Ratios

  • The Gross Profit Margin over the past 4 years for LSB is 79.48%.
  • The Selling, General & Administrative Expenses for LSB have been equal to 74.66% of Gross Profit Margin.
  • The Research & Development expenses have been 52.81% of Revenue.
  • The Interest Expense is -10.23% of Operating Income.
  • The Net Earning history of LSB is -75.59% of Total Revenues.
  • Per Share Earnings over the last 4 years have been positive in 0 years.

LakeShore Biopharma Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: LSB
Website: lakeshorebio.com

Debt

Debt-to-Equity Ratio: 0.61
Current Ratio: 1.17
Quick Ratio: 0.79

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

LSB Technical Analysis vs Fundamental Analysis

Buy
55
LakeShore Biopharma (LSB) is a Buy

Is LakeShore Biopharma a Buy or a Sell?